Breast Cancer HER2 (ERBB2) Status by Next-Generation Sequencing Compared to Traditional Methods

被引：0
|
作者：
Russell, Meaghan K. [1 ]
Pantazi, Angeliki [1 ]
Lyle, Stephen [2 ]
Tse, Julie Y. [3 ]
机构：
[1] KEW Inc, Lethbridge, AB, Canada
[2] Univ Massachusetts, Worcester, MA 01605 USA
[3] KEW Inc, Tufts Med Ctr, Boston, MA USA
来源：
LABORATORY INVESTIGATION | 2018年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
291
引用
收藏
页码：103 / 103
页数：1
相关论文
共 50 条
  • [21] Treatment options in ErbB2 (HER2)-overexpressing breast cancer
    Jackisch, Christian
    BREAST CARE, 2008, 3 : 1 - 1
  • [22] Challenges in the treatment of ErbB2 (HER2)-positiive breast cancer
    Jackisch, Christian
    EJC SUPPLEMENTS, 2008, 6 (05): : 7 - 14
  • [23] Next-Generation Sequencing for HER2 Status in Breast Cancer: Comparison with Immunohistochemistry and in situ Hybridization by 2018 Focused Update
    Mooney, Kelly
    Stehr, Henning
    Kunder, Christian
    Zehnder, James
    Allison, Kimberly
    Lin, Chieh-Yu
    LABORATORY INVESTIGATION, 2019, 99
  • [24] Next-Generation Sequencing for HER2 Status in Breast Cancer: Comparison with Immunohistochemistry and in situ Hybridization by 2018 Focused Update
    Mooney, Kelly
    Stehr, Henning
    Kunder, Christian
    Zehnder, James
    Allison, Kimberly
    Lin, Chieh-Yu
    MODERN PATHOLOGY, 2019, 32
  • [25] Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
    Nakamura, Kohei
    Aimono, Eriko
    Oba, Junna
    Hayashi, Hideyuki
    Tanishima, Shigeki
    Hayashida, Tetsu
    Chiyoda, Tatsuyuki
    Kosaka, Takeo
    Hishida, Tomoyuki
    Kawakubo, Hirohumi
    Kitago, Minoru
    Okabayashi, Koji
    Funakoshi, Takeru
    Okita, Hajime
    Ikeda, Sadakatsu
    Takaishi, Hiromasa
    Nishihara, Hiroshi
    MEDICAL ONCOLOGY, 2021, 38 (04)
  • [26] Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
    Kohei Nakamura
    Eriko Aimono
    Junna Oba
    Hideyuki Hayashi
    Shigeki Tanishima
    Tetsu Hayashida
    Tatsuyuki Chiyoda
    Takeo Kosaka
    Tomoyuki Hishida
    Hirohumi Kawakubo
    Minoru Kitago
    Koji Okabayashi
    Takeru Funakoshi
    Hajime Okita
    Sadakatsu Ikeda
    Hiromasa Takaishi
    Hiroshi Nishihara
    Medical Oncology, 2021, 38
  • [27] ERBB2 Amplification Detected by Next Generation Sequencing Is Concordant with HER2 Immunohistochemical Expression in Uterine Serous Carcinoma
    Robinson, Carrie
    Harrison, Beth
    Dong, Fei
    Perry, Caitlin
    Nucci, Marisa
    Kolin, David
    MODERN PATHOLOGY, 2019, 32
  • [28] ERBB2 Amplification Detected by Next Generation Sequencing Is Concordant with HER2 Immunohistochemical Expression in Uterine Serous Carcinoma
    Robinson, Carrie
    Harrison, Beth
    Dong, Fei
    Perry, Caitlin
    Nucci, Marisa
    Kolin, David
    LABORATORY INVESTIGATION, 2019, 99
  • [29] Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
    Harari, D
    Yarden, Y
    ONCOGENE, 2000, 19 (53) : 6102 - 6114
  • [30] Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
    Daniel Harari
    Yosef Yarden
    Oncogene, 2000, 19 : 6102 - 6114
12345